🔗 Permalink

Inventor profile of:

Robert Schlegl

City:

Siegenfeld

Country:

Austria

Published Applications:

Last publication date:

2025-03-06

Top Assignees for applications by Robert Schlegl

The entities that hold a legal rights for patent applications filed by inventor Schlegl Robert:

Valneva Austria GmbH 25 Vienna, Austria
Valneva SE 11 Nantes, France
Valneva SE 3 Lyon, France
Intercell AG 2 Vienna, Austria
Valneva Austria GmbH 2 Vienna, Australia
Dynavax Technologies Corporation 1 Emeryville, CA United States

Recent patent applications by Schlegl Robert

Robert Schlegl from Siegenfeld, AT has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2025-03-06

US20250073326A1

Human necessities

METHOD OF PRODUCING PHARMACEUTICAL COMPOSITIONS COMPRISING IMMUNOGENIC CHIKUNGUNYA VIRUS CHIKV-DELTA5NSP3

#2 | 2025-01-16

US20250018023A1

Human necessities

Zika Virus Vaccine

#3 | 2024-04-04

US20240108712A1

Human necessities

Zika virus vaccine

#4 | 2024-01-25

US20240026412A1

Chemistry; metallurgy

IMPROVED METHODS OF PRODUCING A LIPIDATED PROTEIN

#5 | 2023-12-14

US20230398210A1

Human necessities

IMPROVEMENTS IN VACCINE FORMULATIONS FOR MEDICAL USE

#6 | 2023-09-21

US20230295245A1

Chemistry; metallurgy

MUTANT FRAGMENTS OF OSPA AND METHODS AND USES RELATING THERETO

#7 | 2023-09-21

US20230293661A1

Human necessities

Method of producing pharmaceutical compositions comprising immunogenic chikungunya virus CHIKV-delta5NSP3

#8 | 2023-07-20

US20230226165A1

Human necessities

Zika virus vaccine

#9 | 2023-02-09

US20230038284A1

Human necessities

CpG-adjuvanted SARS-CoV-2 virus vaccine

#10 | 2022-09-22

US20220298493A1

Chemistry; metallurgy

INACTIVATION PROCESS FOR VIRUSES

#11 | 2022-09-15

US20220288185A1

Human necessities

CHIKUNGUNYA VACCINE FORMULATIONS

#12 | 2022-09-01

US20220273786A1

Human necessities

Zika virus vaccine

#13 | 2022-04-28

US20220125917A1

Human necessities

METHODS FOR PREPARING ALUMINUM PRECIPITATE COMPOUNDS FOR USE IN THERAPEUTICS AND VACCINES

#14 | 2022-01-20

US20220016230A1

Human necessities

Method of producing pharmaceutical compositions comprising immunogenic chikungunya virus CHIKV-Delta5NP3

#15 | 2021-10-21

US20210322534A1

Human necessities

Method of producing pharmaceutical compositions comprising immunogenic Chikungunya virus CHIKV-Delta5nsP3

#16 | 2021-04-01

US20210093707A1

Human necessities

Zika virus purification

#17 | 2020-12-10

US20200384099A1

Human necessities

Zika virus vaccine

#18 | 2020-11-26

US20200368342A1

Human necessities

Virus purification

#19 | 2020-11-19

US20200360511A1

Human necessities

Aluminum compounds for use in therapeutics and vaccines

#20 | 2020-11-05

US20200347364A1

Chemistry; metallurgy

Aseptic purification process for viruses

#21 | 2020-07-30

US20200239525A1

Chemistry; metallurgy

Mutant fragments of OspA and methods and uses relating thereto

#22 | 2020-06-25

US20200197506A1

Human necessities

Virus purification

#23 | 2019-01-10

US20190008945A1

Human necessities

Zika virus purification

#24 | 2018-12-27

US20180371027A1

Chemistry; metallurgy

Zika virus vaccine

#25 | 2018-12-27

US20180369359A1

Human necessities

Virus purification

#26 | 2018-12-20

US20180362937A1

Chemistry; metallurgy

Virus purification

#27 | 2018-12-20

US20180362936A1

Chemistry; metallurgy

Zika virus purification

#28 | 2018-05-03

US20180119110A1

Chemistry; metallurgy

Aseptic purification process for viruses

#29 | 2017-10-19

US20170296656A1

Human necessities

Methods for preparing aluminum precipitate compounds for use in therapeutics and vaccines

#30 | 2017-04-13

US20170101446A1

Chemistry; metallurgy

Mutant fragments of OspA and methods and uses relating thereto

#31 | 2016-12-15

US20160362480A1

Chemistry; metallurgy

NOVEL OPRF/I FUSION PROTEINS, THEIR PREPARATION AND USE

#32 | 2016-11-10

US20160324959A1

Human necessities

Aluminum compounds for use in therapeutics and vaccines

#33 | 2016-04-28

US20160114033A1

Human necessities

Aluminum compounds for use in therapeutics and vaccines

#34 | 2015-08-20

US20150232517A1

Chemistry; metallurgy

MUTANT FRAGMENTS OF OspA AND METHODS AND USES RELATING THERETO

#35 | 2015-08-06

US20150216967A1

Human necessities

IC31 nanoparticles

#36 | 2014-02-20

US20140050756A1

Chemistry; metallurgy

OprF/I fusion proteins, their preparation and use

#37 | 2013-10-24

US20130280295A1

Human necessities

Aluminum compounds for use in therapeutics and vaccines

#38 | 2013-10-10

US20130266575A1

Human necessities

OprF/I AGENTS AND USE THEREOF IN HOSPITALIZED AND OTHER PATIENTS

#39 | 2012-12-06

US20120308618A1

Human necessities

1C31 nanoparticles

InventorID:

476685 ⎘